Less profitable than peers
ROE of 5.7% is below the speciality retail median of 16.4%.
Importance 55 / 95 · profitability
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
ROE of 5.7% is below the speciality retail median of 16.4%.
Importance 55 / 95 · profitability
Trades at 162.14× earnings — 46% above the speciality retail median of 111.35×.
Importance 48 / 95 · valuation
Classified by the exchange under Consumer Discretionary › Consumer Services › Retailing › Speciality Retail.
Peer set used on this page: 2 speciality retail.
Only FY2026 annual results are loaded, so a multi-year growth rate can't be calculated yet. Revenue was ₹5,248 cr and net profit ₹476 cr in FY2026.
Revenue and profit over the loaded history are shown above.
In Q2 FY27 (Jul–Sep 2026), revenue was ₹2,845 cr (up 35.7% on the same quarter last year) and net profit ₹232 cr (up 125%).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 net profit was ₹232 cr, up 124.7% from ₹103 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 revenue was ₹2,845 cr, up 35.7% from ₹2,096 cr in Q2 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q2 FY27 net profit grew 124.7% while revenue grew 35.7% vs the same quarter last year — a gap of 89.0 percentage points.
Rule QTR_PROFIT_VS_REVENUE_GROWTH
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q2 FY26 | 2,096 | — | 103 | — | 4.9% |
| Q3 FY26 | 2,308 | — | 133 | — | 5.8% |
| Q4 FY26 | 2,516 | — | 204 | — | 8.1% |
| Q1 FY27 | 2,714 | — | 228 | — | 8.4% |
| Q2 FY27 | 2,845 | +35.7% | 232 | +124.7% | 8.2% |
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
No verified corporate actions on record for this company.
EBITDA margin was 22.5% in FY2026. ROE was 5.2% and ROCE 8.3% in FY2026.
ROE of 5.7% is below the speciality retail median of 16.4%.
Rule ROE_BELOW_PEER_MEDIAN
It had little or no debt in FY2026 (debt-to-equity 0.01x). Operating cash flow was 2.16x net profit.
Leverage and cash generation over the loaded history are shown above.
Its peer group is too small for a meaningful ranking.
Ranked against 2 speciality retail (FY2026, consolidated).
Not enough peers in this set report the underlying metrics yet for a ranking.
Trades at 162.14× earnings — 46% above the speciality retail median of 111.35×.
Rule PE_ABOVE_PEERS
On the trailing twelve months. Last full year: P/E 258.0× · P/S 14.4× · ROE 5.7%. TTM and full-year profit and revenue and EBITDA differ by more than 15% — a one-off in a recent quarter is moving the trailing figure; weigh it against the full year.
The share price is up 78.7% over 1 year. These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is at its 52-week high; price history covers less than 3 years.
Long-term price performance is shown above.
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY26 |
|---|---|
| Revenue | 5,248 |
| Total income | 5,450 |
| EBITDA | 1,183 |
| Profit before tax | 616 |
| Net profit | 476 |
| EPS (₹) | 2.8 |
| Net worth | 9,119 |
| Total debt | 79 |
| Operating cash flow | 1,028 |
| Free cash flow | 381 |
| Ratio | FY26 |
|---|---|
| Growth | |
| Revenue growth YoY | — |
| Profit growth YoY | — |
| Profitability | |
| EBITDA margin % | 22.5 |
| Net margin % | 8.7 |
| Return on equity % | 5.2 |
| Return on capital % | 8.3 |
| Leverage & cash | |
| Debt to equity | 0.01 |
| Cash flow ÷ profit | 2.16 |
| Current ratio | 3.50 |